» Articles » PMID: 18618497

Hypoxia-regulated Protein Expression, Patient Characteristics, and Preoperative Imaging As Predictors of Survival in Adults with Glioblastoma Multiforme

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2008 Jul 12
PMID 18618497
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Regions of hypoxia within glioblastoma multiforme (GBM) are common and may influence a tumor's aggressiveness, response to treatment, and the patient's overall survival. In this study, the authors examined 4 markers of hypoxia (hypoxia-inducible factor 1 [HIF-1alpha], glucose transporter 1 [GLUT-1], vascular endothelial growth factor [VEGF], and carbonic anhydrase 9 [CA IX]), cellular proliferation and microvascular density (MVD) indices, extent of surgical resection, and preoperative imaging characteristics and compared them with the overall survival rates of adults with GBM.

Methods: In this retrospective cohort study, patients who had lower grade astrocytomas were compared with patients who had GBM to verify that the methods used could establish differences between tumor grades. By using preoperative imaging, the amount of necrosis was established versus the overall tumor area. The authors also compared preoperative images with postoperative images to define the amount of tumor resected; and they compared molecular markers, proliferation, MVD, and imaging studies with survival among patients who had GBM.

Results: The hypoxia-regulated molecules (HRMs) and indices for MVD and cellular proliferation were associated significantly with tumor grade. Survival was improved when >or=95% of the tumor was resected. Although the total tumor area was associated with overall survival, no differences were observed when the amount of necrosis or a tumor necrosis index (area of necrosis/area of tumor) was compared with survival. The findings indicated that GLUT-1 and VEGF were correlated with survival after controlling for age.

Conclusions: Tumor grade was differentiated with HRMs, MVD, and proliferation, but only GLUT-1 predicted survival in this group of patients with GBM. The results suggested that GLUT-1 may be an important independent prognostic indicator.

Citing Articles

Role of Sodium-Dependent Vitamin C Transporter-2 and Ascorbate in Regulating the Hypoxic Pathway in Cultured Glioblastoma Cells.

Burgess E, Praditi C, Phillips E, Vissers M, Robinson B, Dachs G J Cell Biochem. 2024; 126(1):e30658.

PMID: 39382087 PMC: 11729540. DOI: 10.1002/jcb.30658.


Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative Review.

Leitch I, Gerometta M, Eichenbaum D, Finger R, Steinle N, Baldwin M Ophthalmol Ther. 2024; 13(7):1857-1875.

PMID: 38824253 PMC: 11178757. DOI: 10.1007/s40123-024-00973-4.


Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis.

Wang L, Liu W, Broussy S, Han B, Fang H Front Pharmacol. 2024; 14:1307860.

PMID: 38239196 PMC: 10794590. DOI: 10.3389/fphar.2023.1307860.


Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance.

Kang N, Liang X, Fan B, Zhao C, Shen B, Ji X Cancers (Basel). 2022; 14(22).

PMID: 36428773 PMC: 9688485. DOI: 10.3390/cancers14225681.


Comparison of efficacy and safety of bevacizumab biosimilar and original bevacizumab in non-squamous non-small cell lung cancer: a systematic review and meta-analysis.

Xiao X, Zhang G, Sun B, Wang C, Wang X, Kong F Transl Cancer Res. 2022; 11(6):1472-1482.

PMID: 35836506 PMC: 9273685. DOI: 10.21037/tcr-22-71.


References
1.
Gillespie D, Whang K, Ragel B, Flynn J, Kelly D, Jensen R . Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res. 2007; 13(8):2441-8. DOI: 10.1158/1078-0432.CCR-06-2692. View

2.
Behrem S, Zarkovic K, Eskinja N, Jonjic N . Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. Croat Med J. 2005; 46(3):417-22. View

3.
Yao Y, Kubota T, Takeuchi H, Sato K . Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Neuropathology. 2005; 25(3):201-6. DOI: 10.1111/j.1440-1789.2005.00632.x. View

4.
Hammoud M, Sawaya R, Shi W, Thall P, Leeds N . Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol. 1996; 27(1):65-73. DOI: 10.1007/BF00146086. View

5.
Pope W, Sayre J, Perlina A, Villablanca J, Mischel P, Cloughesy T . MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005; 26(10):2466-74. PMC: 7976216. View